683 related articles for article (PubMed ID: 20685224)
21. Studies on the adsorption and desorption of mitoxantrone to lauric acid/albumin coated iron oxide nanoparticles.
Zaloga J; Feoktystov A; Garamus VM; Karawacka W; Ioffe A; Brückel T; Tietze R; Alexiou C; Lyer S
Colloids Surf B Biointerfaces; 2018 Jan; 161():18-26. PubMed ID: 29035747
[TBL] [Abstract][Full Text] [Related]
22. Superparamagnetic iron oxide nanoparticles encapsulated in biodegradable thermosensitive polymeric micelles: toward a targeted nanomedicine suitable for image-guided drug delivery.
Talelli M; Rijcken CJ; Lammers T; Seevinck PR; Storm G; van Nostrum CF; Hennink WE
Langmuir; 2009 Feb; 25(4):2060-7. PubMed ID: 19166276
[TBL] [Abstract][Full Text] [Related]
23. Superparamagnetic reconstituted high-density lipoprotein nanocarriers for magnetically guided drug delivery.
Sabnis S; Sabnis NA; Raut S; Lacko AG
Int J Nanomedicine; 2017; 12():1453-1464. PubMed ID: 28260891
[TBL] [Abstract][Full Text] [Related]
24. Promising approaches in using magnetic nanoparticles in oncology.
Mikhaylov G; Vasiljeva O
Biol Chem; 2011 Nov; 392(11):955-60. PubMed ID: 21848508
[TBL] [Abstract][Full Text] [Related]
25. Cell Labeling and Targeting with Superparamagnetic Iron Oxide Nanoparticles.
Tefft BJ; Uthamaraj S; Harburn JJ; Klabusay M; Dragomir-Daescu D; Sandhu GS
J Vis Exp; 2015 Oct; (105):e53099. PubMed ID: 26554870
[TBL] [Abstract][Full Text] [Related]
26. Recent Advances in Superparamagnetic Iron Oxide Based Nanoprobes as Multifunctional Theranostic Agents for Breast Cancer Imaging and Therapy.
Zheng J; Ren W; Chen T; Jin Y; Li A; Yan K; Wu Y; Wu A
Curr Med Chem; 2018; 25(25):3001-3016. PubMed ID: 28685676
[TBL] [Abstract][Full Text] [Related]
27. Effect of surface coating on the biocompatibility and in vivo MRI detection of iron oxide nanoparticles after intrapulmonary administration.
Al Faraj A; Shaik AP; Shaik AS
Nanotoxicology; 2015; 9(7):825-34. PubMed ID: 26356541
[TBL] [Abstract][Full Text] [Related]
28. Tracking stem cells with superparamagnetic iron oxide nanoparticles: perspectives and considerations.
Jasmin ; de Souza GT; Louzada RA; Rosado-de-Castro PH; Mendez-Otero R; Campos de Carvalho AC
Int J Nanomedicine; 2017; 12():779-793. PubMed ID: 28182122
[TBL] [Abstract][Full Text] [Related]
29. Mitoxantrone-loaded superparamagnetic iron oxide nanoparticles as drug carriers for cancer therapy: Uptake and toxicity in primary human tubular epithelial cells.
Cicha I; Scheffler L; Ebenau A; Lyer S; Alexiou C; Goppelt-Struebe M
Nanotoxicology; 2016; 10(5):557-66. PubMed ID: 26468004
[TBL] [Abstract][Full Text] [Related]
30. Superparamagnetic iron oxide nanoparticles: promises for diagnosis and treatment of cancer.
Laurent S; Mahmoudi M
Int J Mol Epidemiol Genet; 2011; 2(4):367-90. PubMed ID: 22199999
[TBL] [Abstract][Full Text] [Related]
31. Development and Characterization of Magnetite/Poly(butylcyanoacrylate) Nanoparticles for Magnetic Targeted Delivery of Cancer Drugs.
López-Viota M; El-Hammadi MM; Cabeza L; Prados J; Melguizo C; Ruiz Martinez MA; Arias JL; Delgado ÁV
AAPS PharmSciTech; 2017 Nov; 18(8):3042-3052. PubMed ID: 28508129
[TBL] [Abstract][Full Text] [Related]
32. Oxide and hybrid nanostructures for therapeutic applications.
Chandra S; Barick KC; Bahadur D
Adv Drug Deliv Rev; 2011 Nov; 63(14-15):1267-81. PubMed ID: 21729727
[TBL] [Abstract][Full Text] [Related]
33. Current trends in chemical modifications of magnetic nanoparticles for targeted drug delivery in cancer chemotherapy.
Gholami A; Mousavi SM; Hashemi SA; Ghasemi Y; Chiang WH; Parvin N
Drug Metab Rev; 2020 Feb; 52(1):205-224. PubMed ID: 32083952
[TBL] [Abstract][Full Text] [Related]
34. Superparamagnetic nanoparticles for biomedical applications.
Xiao Y; Du J
J Mater Chem B; 2020 Jan; 8(3):354-367. PubMed ID: 31868197
[TBL] [Abstract][Full Text] [Related]
35. The use of magnetite nanoparticles for implant-assisted magnetic drug targeting in thrombolytic therapy.
Kempe M; Kempe H; Snowball I; Wallén R; Arza CR; Götberg M; Olsson T
Biomaterials; 2010 Dec; 31(36):9499-510. PubMed ID: 20732712
[TBL] [Abstract][Full Text] [Related]
36. Interaction of functionalized superparamagnetic iron oxide nanoparticles with brain structures.
Cengelli F; Maysinger D; Tschudi-Monnet F; Montet X; Corot C; Petri-Fink A; Hofmann H; Juillerat-Jeanneret L
J Pharmacol Exp Ther; 2006 Jul; 318(1):108-16. PubMed ID: 16608917
[TBL] [Abstract][Full Text] [Related]
37. The internalization pathway, metabolic fate and biological effect of superparamagnetic iron oxide nanoparticles in the macrophage-like RAW264.7 cell.
Gu J; Xu H; Han Y; Dai W; Hao W; Wang C; Gu N; Xu H; Cao J
Sci China Life Sci; 2011 Sep; 54(9):793-805. PubMed ID: 21922429
[TBL] [Abstract][Full Text] [Related]
38. Magnetic nanoparticles for magnetic drug targeting.
Lyer S; Singh R; Tietze R; Alexiou C
Biomed Tech (Berl); 2015 Oct; 60(5):465-75. PubMed ID: 26351783
[TBL] [Abstract][Full Text] [Related]
39. Mesoporous silica nanoparticles for intracellular controlled drug delivery.
Vivero-Escoto JL; Slowing II; Trewyn BG; Lin VS
Small; 2010 Sep; 6(18):1952-67. PubMed ID: 20690133
[TBL] [Abstract][Full Text] [Related]
40. Modelling the effect of SPION size in a stent assisted magnetic drug targeting system with interparticle interactions.
Mardinoglu A; Cregg PJ
ScientificWorldJournal; 2015; 2015():618658. PubMed ID: 25815370
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
